Table 4.
Univariate analysis for OS
| Parameter | OS (%) | p |
|---|---|---|
| Age | ||
| 70-74 (n = 20) | 37.9 | 0.71 |
| ≥75 (n = 20) | 18.2 | |
| Gender | ||
| Male (n = 33) | 26.8 | 0.88 |
| Female (n = 7) | 38.0 | |
| AJCC stage | ||
| I-III (n = 35) | 31.8 | 0.07 |
| IV (n = 5) | 0.0 | |
| Response | ||
| CR + PR (n = 28) | 42.0 | <0.001 |
| SD + PD (n = 12) | 0.0 | |
| Chemotherapy | ||
| Standard dose (n = 10) | 12.5 | 0.05 |
| Modified dose (n = 18) | 53.8 | |
| Lower dose (n = 12) | 0.0 | |
AJCC = American Joint Committee on Cancer; CR = complete response; OS = overall survival; PD = progression disease; PR = partial response; SD = stable disease.